SCT

Stem Cell Therapy Fellowship

Overview

A growing crisis regarding organ transplants and an aging population has intensified the search for new and alternative therapies. With an approximate 90,000 patients on the current U.S. transplant-waiting list, a wide array of critical medical needs have gone unmet—many of which can potentially be addressed by regenerative technologies.

Regenerative medicine is a rapidly emerging branch of medicine with the overarching goal of restoring organ and/or tissue function for patients with serious injuries or chronic disease, during which the body’s own responses are insufficient.

speaker img

MMI has recognized the need for current and up-to-date knowledge regarding stem cells, coupled with the need to disseminate information amongst physicians and healthcare professionals—thus creating the world's first Stem Cell Fellowship program.

New and current regenerative medical technologies can harness the power of stem cells in order to create living, functional tissues, which collectively regenerate and repair tissue and bodily organs that have been damaged due to age, disease, or congenital defects. Stem cells have the capability to access these damaged areas, restoring cells and tissues by performing a repair and renewal process, which ultimately reestablishes functionality.

In this modular training program, a group of experienced academics led by Dr. Sharon McQuillan, with extensive backgrounds in stem cell transplantation, present a series of topics that review the general principles and practices of stem cell biology, in addition to evidence-based treatments for physicians that can help optimize their patients’ health.

After completion of this modular training program, physicians will be able to choose which stem cell protocols to recommend to their patients. Sign up today, and become a pioneer in stem cell therapy and the future of regenerative medicine.

Stem Cell Fellowship Modules

The Fellowship in Stem Cell Therapy is comprised of a five modular series including four didactic modules and one clinical intensive.

  • Module I: The Biological and Molecular Basis for Regenerative Medicine
  • Module II: Best Practices in Regenerative Medicine
  • Module III: In-Office Applications of Regenerative Therapies: Focus on Cardiovascular, Vascular, and Respiratory Conditions
  • Module IV: In-Office Applications of Regenerative Therapies: Focus on Musculoskeletal, Neurological and Neuro-Degenerative Conditions
  • Module V: Autologous Adult Stem Cell Harvesting and Isolation Techniques (Hands-On Clinical Module)

Requirements:

  • Completion of Modules I-V
  • Written Examination In Stem Cell Therapy
  • Active A4M Membership
  • Open to MD, DO, PA*, NP*

Locations for Live Modules

Ageless Institute, Aventura, Florida, USA

Ageless Institute of Aventura, Florida offers Anti-Aging, Aesthetic, and Weight Loss treatments. Dr. Sharon McQuillan owns and operates the institute. She is certified in the therapeutic and cosmetic use of Botox®, the cosmetic use of facial fillers, sclerotherapy, mesotherapy, chemical peels, the aesthetic use of lasers, tumescent syringe liposculpture, endovenous laser ablation, and ambulatory phlebectomy.

Module I: The Biological and Molecular Basis for Regenerative Medicine

Module I

The Biological and Molecular Basis for Regenerative Medicine

$2,500.00
ACCESS PREVIEW   To Register Please
Call (561) 997-0112

The first module of the Stem Cell Fellowship will provide a detailed foundation of the concepts of cellular biology and physiology, stem cell biology, and the intricacies of cellular signaling and cell phenotypes that are essential in regenerative medicine. All stem cell sources will be reviewed including fetal, placental, umbilical, cord blood, embryonic, bone marrow derived, adipose derived, peripheral blood, and induced pluripotent stem cells. Current stem cell markers, as well as the latest cell imaging devices and techniques will be discussed and demonstrated in a live, interactive setting.

Objectives:

Upon completion of the module, the participant will:

  • Review the history and highlights of the field of translational science and regenerative medicine
  • Possess a thorough understanding of cell anatomy and biology, including cell structure, function, transport, and the cell cycle
  • Understand basic stem cell properties and processes, including self-renewal and cell cycle regulation
  • Develop a working knowledge of cell-ECM(extra cellular matrix) and cell-EMT (epithelial mesenchymal) transitions
  • Discuss the importance of stem cell niche environments and cell signaling
  • Analyze the properties, mechanism of action, features, benefits, drawbacks, and applications of the various stem cell sources:
    • Embryonic
    • Amniotic
    • Fetal tissue
    • Cord blood
    • Placental
    • Peripheral blood
    • Umbilical
    • Bone marrow derived
    • Adipose derived
    • Induced pluripotent
  • Explore the principles and ethical considerations of cloning
  • Describe the characteristics and composition of mesenchymal stem cell and their applications
  • Compare and contrast the risks and benefits of autologous versus allogeneic stem cell approaches
  • Develop a working knowledge of cell markers specific to stem cells and their importance in regenerative medicine
  • Participate in interactive sessions with leading experts viewing live stem cell demonstrations and specimens
  • Analyze the various roles of growth factors in cell regeneration and rejuvenation
  • Discuss the importance of cell markers in determining cell viability and effectiveness in a clinical and/or research setting
  • Describe the relationship of telomeres as it applies to translational and regenerative medicine
  • Participate in interactive sessions with leading experts demonstrating and comparing the latest cell imaging and labeling techniques, including magnetic resonance imaging, flow cytometry, ultrasound, single photon emission computed tomography, and positron emission tomography.

Module II: Best Practices in Cell Biology

Module II

Best Practices in Cell Biology

$2,500.00
To Register Please
Call (561) 997-0112

The second module of the Fellowship in Stem Cell Therapies will provide a detailed foundation of the best practices needed to successfully incorporate cellular therapies into a clinical or research setting. This module will review the science of all current autologous stem cell harvesting and isolation techniques. The concepts of cell culture and expansion, isolation, cell banking, cryopreservation, and cell validation strategies will be reviewed. Current compliance and regulatory practices, guidelines, and statutes regarding cellular products and procedures will be presented by thought leaders in the field of regenerative medicine

Objectives:

Upon completion of the module, the participant will:

  • Develop expert understanding of the harvesting methods employed for autologous bone marrow, adipose, and peripheral blood stem cell procedures
  • Compare stem cell isolation methods for reproducibility, robustness, and cell viability
  • Discuss the risks, benefits, applications, and current legalities surrounding cell cryopreservation and cell banking
  • Understand the importance of cell validation studies and cell product standardization as it relates to clinical treatment and research
  • Become familiar with cell culturing and expansion techniques, including benefits, drawbacks, mechanisms of action, and practical application
  • Possess a working knowledge of the use of biomaterials and bio-scaffolds and their role in regenerative and translational medicine
  • Discuss the basics of tissue engineering and evaluate current research pertaining to the subject
  • Review the concepts and implementation of Good Tissue Practices (GTP)
  • Learn the importance of Good Manufacturing Practices (cGMP) as it relates to the field of regenerative and translational medicine
  • Understand the premise of platelet rich plasma and its adjunctive uses in regenerative medicine
  • Analyze current state, US governmental and worldwide agency position on human cells, tissues, and cellular and tissue-based products
  • Investigate guidelines surrounding Institutional Review Board (IRB) approved clinical studies and their importance in the field of regenerative and translational medicine
  • Learn best practices for performing in-office stem cell research according to current guidelines
  • Review the ethical considerations surrounding cellular therapy
  • Participate in interactive sessions with leading experts evaluating case studies of actual incidents to evaluate ethical, legal, and regulatory considerations

Module III: Regenerative Therapies: Focus on Cardiovascular, Vascular, and Respiratory Conditions

Module III

Regenerative Therapies: Focus on Cardiovascular, Vascular, and Respiratory Conditions

$2,500.00
To Register Please
Call (561) 997-0112

The third module of the Fellowship in Stem Cell Therapies will provide a detailed foundation regarding the treatment of cardiovascular, vascular, and respiratory conditions utilizing various stem cell sources. An overview of each disease condition and current standard of care will be examined. A comprehensive analysis of current research regarding these treatments will be presented.

Objectives:

Upon completion of the module, the participant will:

  • Review the disease background, statistics, etiology, current standard of care, and issues/controversies surrounding current treatments for many cardiovascular conditions, including:
    • Myocardial infarction
    • Ischemic cardiomyopathy
    • Atherosclerosis
  • Discuss the mechanism of action, structure, and function of cardiopoietic stem cells
  • Analyze the various cell therapies available for cardiovascular regeneration, including induced pluripotent, umbilical, mesenchymal stem cells, and biomaterials
  • Possess a working knowledge of clinical studies published outlining the treatment of cardiovascular conditions
  • Participate in interactive case study sessions to successfully provide treatment strategies for cardiovascular conditions, including patient selection, diagnosis, risks, and benefits
  • Review the disease background, statistics, etiology, current standard of care, and issues/controversies surrounding current treatments for many vascular conditions, including:
    • Intermittent claudication
    • Peripheral artery disease
    • Critical limb ischemia
    • Deep vein thrombosis
  • Discuss the mechanism of action, structure, and function of vascular stem cells
  • Analyze the various cell therapies available for vascular regeneration, including induced pluripotent, umbilical, mesenchymal stem cells, and biomaterials
  • Possess a working knowledge of clinical studies published outlining the treatment of vascular conditions
  • Participate in interactive case study sessions to successfully provide treatment strategies for vascular conditions, including patient selection, diagnosis, risks, and benefits
  • Gain expert knowledge regarding the disease background, statistics, etiology, current standard of care, and issues/controversies surrounding current treatments for many pulmonary conditions, including:
    • Asthma
    • Chronic Obstructive Pulmonary Disorder (COPD)
    • Idiopathic pulmonary fibrosis
    • Interstitial lung disease
    • Respiratory distress syndrome
    • Acute lung injury
  • Review the structure, function, and mechanisms governing pulmonary cell regeneration
  • Discuss the cell therapies available for pulmonary conditions utilizing various cell types (embryonic, umbilical, fetal, mesenchymal stem cells, etc.) and delivery methods available
  • Analyze current scientific research outlining the treatment of respiratory conditions utilizing stem cells
  • Participate in interactive case study sessions to successfully formulate treatment plans for respiratory conditions including patient selection, diagnosis, risks, and benefits

Module IV: Regenerative Therapies: Focus on Musculoskeletal, Neurological and Neuro-Degenerative Conditions

Module IV

Regenerative Therapies: Focus on Musculoskeletal, Neurological and Neuro-Degenerative Conditions

$2,500.00
To Register Please
Call (561) 997-0112

The fourth module of the Fellowship in Stem Cell Therapies will provide a detailed foundation regarding the treatment of musculoskeletal and neurodegenerative conditions utilizing various stem cell sources. An overview of each disease condition and current standard of care will be examined. A comprehensive analysis of current research regarding these treatments will be presented as well as best practices for in-office applications will be discussed, as applicable.

Objectives:

Upon completion of the module, the participant will:

  • Review the disease background, statistics, etiology, current standard of care, and issues/controversies surrounding current treatments for many musculoskeletal conditions, including:
    • Osteoarthritis
    • Articular cartilage defects
    • Meniscus tears
    • Duchenne muscular dystrophy
    • Degenerative disc disease
    • Rotator cuff injuries
    • Non-union bone fractures
    • Tendon injuries
    • Ligament injuries
    • Joint injuries
  • Discuss the mechanism of action, structure, and function of cartilage regeneration and bone regeneration
  • Analyze the various cell therapies available for musculoskeletal regeneration, including induced pluripotent, umbilical, mesenchymal stem cells, and biomaterials
  • Possess a working knowledge of clinical studies published outlining the treatment of musculoskeletal conditions
  • Participate in interactive case study sessions to successfully provide treatment strategies for musculoskeletal conditions, including patient selection, diagnosis, risks, and benefits
  • Analyze the benefits of using platelet rich plasma (PRP) in orthopedic treatments
  • Gain expert knowledge regarding the disease background, statistics, etiology, current standard of care, and issues/controversies surrounding current treatments for many neurological and neurodegenerative conditions, including:
    • Parkinson’s disease
    • Dementia
    • Alzheimer’s disease
    • Cerebral palsy
    • Stroke
    • Traumatic Brain Injury
    • Autism
    • Amyotrophic lateral sclerosis (ALS)
    • Huntington’s disease
    • Spinal cord injury
    • Neuropathy
  • Review the structure, function, and mechanisms governing neural cell regeneration
  • Discuss the cell therapies available for neurological and neurodegenerative conditions utilizing various cell types (embryonic, umbilical, fetal, mesenchymal stem cells, etc.) and delivery methods available
  • Analyze current scientific research outlining the treatment of neurological and neurodegenerative conditions utilizing stem cells
  • Participate in interactive case study sessions to successfully formulate treatment plans for neurodegenerative and neurological conditions including patient selection, diagnosis, risks, and benefits

Module V: Stem Cell Harvesting and Isolation

Module V

Stem Cell Harvesting and Isolation

$7,500.00
To Register Please
Call (561) 997-0112

Module V of the Fellowship in Stem Cell Therapies provides an approved office-based method for the isolation of autologous adult bone marrow and platelet rich plasma (PRP). Autologous adult stem cell harvesting involves the removal of bone marrow from the patient followed by a laboratory process that isolates the stem cells from the aspirate. Platelet rich plasma is an autologous product obtained from whole blood via density gradient centrifugation. The course curriculum consists of home study materials, plus two days of combination didactic, hands-on clinical and laboratory experience.

Objectives:

Upon completion of the module, the participant will:

  • Review basis concepts of stem cell biology
  • Compare and contrast adipose harvesting techniques
  • Analyze bone marrow harvesting techniques
  • Perform bone marrow harvesting techniques
  • Possess a working knowledge and demonstrate proficiency in good tissue practices, aseptic technique, sterile technique, as well as the tumescent technique
  • Demonstrate competence in operating various laboratory equipment utilized to process adult stem cells and platelet rich plasma
  • Participate in cell counting and validation techniques analyzing live samples
  • Participate in the collection and processing of platelet rich plasma
  • Learn best practices for implementing regenerative medicine techniques
  • Discuss current regulatory and compliance requirements for in-office regenerative medicine treatments
  • Ability to retake course for periodic updates at no charge

Elective: Regenerative Orthopedic Treatments

August 12

$2,500.00
ADD TO CART  

November 11

$2,500.00
ADD TO CART  

Autologous adult stem cells and platelet rich plasma have been shown to repair injured or diseased structures in the musculoskeletal system. This occurs through cell differentiation, proliferation, and the release of bioactive tissue growth factors.

Course Prerequisites: Successful completion of Stem Cell Harvesting & Isolation Techniques

Objectives:

Upon completion of the module, the participant will:

  • Review anatomy, pathophysiology, and diagnostics associated with arthritis, tendonitis, and acute sports injuries
  • Discuss indications, contraindications, patient selection, pre- and post-treatment instructions, and treatment alternatives for regenerative orthopedic treatments
  • Learn injection techniques for joint injections of the knees, shoulders, hips, and common strains and sprains with and without ultrasound guidance
  • Discuss advantages of using autologous bone marrow and platelet rich plasma for joint injections
  • Learn methods to diagnose, evaluate, and perform tendon and joint injections

Elective: Use of Platelet Rich Plasma in Regenerative Medicine

August 9

$2,500.00
ADD TO CART  

Platelet Rich Plasma (PRP) utilizes the platelets and growth factors in a patient’s blood to initiate connective tissue healing and repair. PRP therapy is a natural progression in an integrative or anti-aging clinic. This course will provide an overview of PRP therapies including protocols, forms, equipment and supply lists, etc. for easy implementation into a medical clinic setting.

Objectives:

Upon completion of the module, the participant will:

  • Understand various FDA-approved methods to process platelet rich plasma (PRP) including: single spin vs. dual spin, concentrations of biological components and growth factor yields, difference in PRP types and PRP kits
  • Discuss indications, contraindications, patient selection, pre- and post-treatment instructions, and treatment alternatives for various PRP indications including:
    • Sports Injuries
    • Skin Rejuvenation (Aesthetic enhancement)
    • Wound Healing
    • Hair Restoration
    • Sexual Enhancement
  • Learn injection techniques for the various PRP indications including: sports injuries, skin rejuvenation and volumization, wound healing, hair restoration, and sexual enhancement
  • Review best practices for successful pricing, marketing, and implementation strategies

Elective: Advanced Regenerative Orthopedic Treatments

Autologous adult stem cells and platelet rich plasma has been shown to repair injured or diseased structures in the musculoskeletal system. This occurs through cell differentiation, proliferation, and the release of bioactive tissue growth factors.

Course Prerequisites: Prior Joint Injection Experience & Successful completion of Stem Cell Harvesting & Isolation Techniques

Objectives:

Upon completion of the module, the participant will:

  • Review anatomy, pathophysiology, and diagnostics associated with arthritis, tendonitis, and acute sports injuries
  • Discuss indications, contraindications, patient selection, pre- and post-treatment instructions, and treatment alternatives for regenerative orthopedic treatments
  • Learn injection techniques for joint injections of the hip, SI joint, spine, wrist, carpal tunnel syndrome, and Achilles tendon with and without ultrasound guidance
  • Discuss advantages of using adult stem cells and platelet rich plasma for joint injections
  • Learn methods to diagnose, evaluate, and perform tendon and joint injections

Staff and Faculty

Sharon McQuillan, MD

Sharon McQuillan, MD

Sharon McQuillan, MD is a board-certified physician specializing in Integrative, Regenerative, and Aesthetic Medicine. Dr. McQuillan is the program director for the Stem Cell Fellowship and has extensive experience in the field of regenerative medicine. She has authored numerous research protocols and serve as a liaison between many governmental agencies, educating them about the promise of regenerative therapies.

Raphael Gonzalez, PhD

Raphael Gonzalez, PhD

Raphael Gonzalez is the Vice-President of Research and Development for BioBox and is responsible for the development of clinical stem cell applications for several disease and trauma states. He has authored numerous research and clinical studies regarding the use of stem cells.

H. Thomas Temple

H. Thomas Temple

H. Thomas Temple MD is board-certified orthopedic surgeon and the Senior Vice President of Tranlational Research and Economic Development as well as the Executive Dean for Research in the College of Allopathic Medicine at Nova Southeastern University. He is an expert in the stem cell applications of bone and cartilage regeneration, tissue banking, and the development of targeted therapies for sarcomas.

Arshed Quyyumi, MD, FACC, FRCP

Arshed Quyyumi, MD, FACC, FRCP

Arshed Quyyumi, MD is a Professor of Cardiology and Co-Director of the Cardiac research Institute at Emory University. Dr. Quyyimi is a thought leader regarding progenitor cells and angiogenesis, biomarkers and vascular genomics, and bone marrow stem cells and has published over 250 papers and landmark studies on these topics.

Thomas Povsic, MD

Thomas Povsic, MD

Thomas Povsic, MD is an Associate Professor of Cardiology and Director of Advanced Biomarkers at Duke University. His extensive research and publications center around progenitor cells and biomarkers for treating refractory angina, peripheral artery disease, and cardiovascular disease.

Gabriel Nistor, MD, PhD

Gabriel Nistor, MD, PhD

Gabriel Nistor, MD is the Vice-President of Research and Development at Aivita Biomedical. Dr. Nistor is a world leader in embryonic stem cell, cancer stem cell, and spinal cord injury research, and holds many patents regarding stem cell treatments and processes. He has been awarded multiple grants from the NIH and CIRM and had published his research extensively.

Ashok Shetty, PhD

Ashok Shetty, PhD

Ashok Shetty, PhD is a Professor and Director of Neurosciences for the Institute of Regenerative Medicine at Texas A & M University, as well as a research career scientist for the Olin Teaugue Veteran’s Affairs Medical Center, Central Texas. Dr. Shetty has over 100+ journal publications with a focus on the use of neural stem cells in promoting brain repair.

Rahul Desai, MD

Rahul Desai, MD

Rahul Desai, MD is a fellowship-trained musculoskeletal and spinal interventional radiologist. He is an internationally recognized expert in platelet rich plasma and stem cell treatments for musculoskeletal conditions and published his results in many peer-reviewed journals.

Shalesh Kaushal, MD

Shalesh Kaushal, MD

Shalesh Kaushal, MD is an Adjunct Professor in the Department of Ophthalmology at New York Medical College. He has published 30+ scientific study publications and has numerous patents involving the use of stem cells in ophthalmology.

Joel Baumgartner, MD

Joel Baumgartner, MD

Joel Baumgartner, MD is a board-certified Sports Medicine specialist and medical director of Rejuv Medical and Orthopedic Medicine in St. Cloud, Minnesota. He is an expert and contributing author on the subjects of prolotherapy, platelet rich plasma, and pain management.

Joseph Purita, MD

Joseph Purita, MD

Joseph Purita, MD is a board-certified orthopedic surgeon and pain management physician from South Florida. Dr. Purita is a renowned pioneer in the use of stem cells and platelet rich plasma for orthopedic conditions.

Stephen Sinatra, MD

Stephen Sinatra, MD

Stephen Sinatra, MD is board-certified cardiologist metabolic cardiology expert, and best-selling author. He has developed numerous supplements and treatment protocols for cardiovascular disease management.

Ernesto Gutierrez, MD

Ernesto Gutierrez, MD

Ernesto Gutierrez, MD is a Professor at Anunauc University School of Medicine and President and Medical Director of the World Stem Cell Clinic, a medical facility specializing in autologous stem cell treatments. Dr. Gutierrez’s area of expertise is in the treatment of autism utilizing stem cells.

Doreen Saltiel, MD

Doreen Saltiel, MD

Doreen Saltiel MD is a board-certified physician in cardiology, internal medicine, and venous and lymphatic disease. Dr. Saltiel is a renowned speaker and educator regarding integrative cardiology.

Jesus Esparragoza, MD

Jesus Esparragoza, MD

Jesus Esparragoza, MD is a board-certifed interventional cardiologist from Mexico. He is a pioneer in stem cell therapies, approving protocols through COFEPRIS (Mexico’s FDA) and currently performs stem cell treatments at ReHealth Clinic.

Roberto Vazquez-Padron, PhD

Roberto Vazquez-Padron, PhD

Roberto Vazquez-Padron is an Associate Professor of the Vascular Biology Institute at the University of Miami Miller School of Medicine. His areas of specialty focus on the role of stem cells in vascular and cardiovascular disease and he has authored 50+ studies on these topics.

Tan Ince, MD, PhD

Tan Ince, MD, PhD

Tan Ince MD is an Associate Professor of Pathology at the University of Miami Miller School of Medicine and former professor of Pathology at Harvard University. His area of expertise and research publication is cancer stem cells.

Anasua Kusari, PhD

Anasua Kusari, PhD

Anasua Kusari, PhD is a scientist and Molecular Biology Core Manager at DaVinci Bioscience. She has decades of experience in cell signaling and protein-protein interactions in mammalian cells. For the last several years she has been working on developing a better understanding of the differentiation of cartilage from bone marrow stromal cells at the molecular level. She had published her work in many peer-reviewed journals.

Robert Bowen, MD

Robert Bowen, MD

Robert Bowen MD is a triple board-certified physician in internal medicine, pulmonary medicine, and sleep medicine as well as an Associate Professor of Medicine and Co-Director of the Internal Medicine internship program at West Virginia University Medical School. He has extensive experience in stem cell therapy for wound healing.

Mukesh Saraiya, MD

Mukesh Saraiya, MD

Mukesh Saraiya MD is a board-certified physician in internal medicine, sleep medicine, and pulmonology, as well as a clinical Associate Professor at the University of Texas. He has experience treating numerous patients with lung disease utilizing autologous stem cells.

Claude Fortin, MD

Claude Fortin, MD

Claude Fortin MD is a board-certified physician in neurology and electroencephalogography, and a Loyola medical school graduate. He specializes in integrative strategies for neurodegenerative disease.

Kevin MacDonald

Kevin MacDonald

Kevin MacDonald has more than 25 years of experience and a successful track record with achieving regulatory market clearances/approvals in the United States and abroad. His main area of expertise is as a regulatory, clinical, and quality consultant working with small medical device startup companies. He has held Vice-President positions at NeoTract, Concentric Medical, and RA/QA/CA positions with Fox Hollow Technologies, Heartport, Cordis, Boston Scientific, and CR Bard.

Nelson Piludu, MT

Nelson Piludu, MT

Nelson Piludu is a medical technologist by training and has over 10 years of experience in the clinical research industry. His area of expertise is platelet rich plasma.

Yvette Blanco-Jivangee, MS

Yvette Blanco-Jivangee, MS

Yvette Jivangee is a clinical research professional with 17 years of experience within the academic and biomedical industries. Her areas of expertise is in regenerative medicine compliance, particularly cGMP, cGTP, and cGLP.

Marisol Castor-Paiz, PhD

Marisol Castor-Paiz, PhD

Marisol Castor-Paiz PhD is an accomplished and highly skilled scientist dedicated to the research and development of pharmaceuticals and medical products from early discovery through regulatory and clinical development.

Marcela Salgado, MD

Marcela Salgado, MD

Marcela Salgado MD is a medical research administrator at the University of Miami Miller School of Medicine with extensive and proven expertise in clinical and translational research and pathology.